The Hemangioma Market: Trends, Treatments, and Opportunities in 2025 The global hemangioma market is experiencing significant evolution, driven by advancements in diagnostics and a deeper understanding of this common vascular anomaly. For B2B buyers, market analysts, and procurement professionals, navigating this complex landscape presents both challenges and unparalleled opportunities. Understanding the market dynamics, from emerging infantile hemangioma treatment options to the burgeoning hemangioma therapeutics pipeline , is crucial for strategic decision-making in 2025. This year promises to redefine patient care and market expansion, making comprehensive insights indispensable. What is Hemangioma and Why It Matters in 2025? Hemangioma, a benign vascular tumor, primarily affects infants and young children, often appearing shortly after birth. While many hemangiomas resolve spontaneously, a significant proportion requires intervention due to potential complications like ulceration...